The press release from Novo Nordisk states that semaglutide 2.4 mg reduces the risk of major adverse cardiovascular events by … read more
A study published in JAMA Network Open looked at low-dose aspirin, stroke prevention and bleeding risk. Prof Stephen Evans, … read more
A new suite of injectable weight loss drugs – GLP-1 receptor agonists – has arrived on the scene in the … read more
The 2-year drugs pilot was announced by the Prime Minister Rishi Sunak today. Prof Giles Yeo, Professor of Molecular … read more
The National Institute for Health and Care Excellence (NICE) has published guidance on the use of semaglutide for managing overweight and … read more
The pharmaceutical company Moderna have released interim top-line findings looking at antibody responses from their Omicron-containing bivalent COVID-19 vaccine. … read more
The British Pharmacological Society and Royal College of Physicians have written a joint report on the role that pharmacogenetics – … read more
It has been reported that the pharmaceutical company Johnson & Johnson have paused the trial of their COVID-19 vaccine due … read more
The pharmaceutical company Lilly have made an announcement on the progress of research into their neutralising antibodies treatment for COVID-19. … read more
It has been reported that the pharmaceutical company Roche, who provide materials for COVID-19 diagnostic tests, have issues in processing … read more
There have been reports that the UK government plans to by COVID-19 antibody tests from the pharmaceutical company Roche. … read more
NICE have issued their draft guidance on Esketamine nasal spray for treatment resistant depression. Dr Paul Keedwell, Consultant Psychiatrist, … read more
The dangers of illegal drugs are well known and rarely disputed, but how harmful are alcohol and tobacco by comparison? … read more
Jacob Rees-Mogg recently apologised to Dr David Nicholl after comparing him to Andrew Wakefield for suggesting that a No Deal … read more
Anticholinergic drugs act on the neurotransmitter acetylcholine in the nervous system and are used to treat a range of conditions such as epilepsy, Parkinson’s disease, urinary incontinence, depression, and allergies. read more
A new study, published by the Economics Evaluation of Health and Care Interventions (EEPRU), has reported that an estimated 237 million medication errors occur in the NHS in England each year. read more
Building on Sally Davies’s vision for integrating genomics into every aspect of the NHS, Dr. Sullivan can discuss some of the latest genomics and population-based genomic analysis is starting to play in understanding the genetic determinants of Alzheimer’s disease. read more
The National Institute for Health and Care Excellence (NICE) has published new guidance which recommends Cetuximab and panitumumab, for previously untreated metastatic colorectal cancer, be moved from the Cancer Drugs Fund into routine use. read more
Immunotherapy has been hailed as an exciting and emerging branch of cancer medicine. Over the last six months we’ve heard about promising results from trials of ipilimumab and nivolumab for melanoma, and nivolumab for lung cancer – but what might be the future of cancer immunotherapy, and might we see it being widely added to the armoury of chemotherapy, radiotherapy and surgery for some cancers? read more
It has been announced that the Cancer Drugs Fund will no longer pay for a number of medicines which were previously available. read more
